Increasing multimorbidity burden after COVID-19 Infection Among People with and without HIV in the United States: Insights from the National Clinical Cohort Collaborative (N3C)

Clicks: 18
ID: 329171
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #201 of 316 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 316 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background People with HIV (PWH) have a disproportionately high burden of chronic comorbidities. However, how their multimorbidity patterns differ from those of the general population and how COVID-19 infection may affect this burden have not been well characterized. Methods We conducted a retrospective cohort study using the National COVID Cohort Collaborative (N3C), including adults aged ≥18 years with a confirmed COVID-19 diagnosis between January 1, 2018, and December 31, 2024. Fourteen chronic comorbidities were identified using N3C concept sets. Exploratory factor analysis was used to identify multimorbidity patterns before and after COVID-19 diagnosis. Results Among 7,500,765 patients with COVID-19, 52,015 (0.7%) were PWH. The median age was 48 years (IQR, 33–63) and 57.3% were female. PWH consistently had a higher multimorbidity burden than PWoH, and this disparity widened after COVID-19: the proportion with ≥ 3 comorbidities rose from 45.0% to 55.9% among PWH versus 22.2% to 29.7% among PWoH. Four multimorbidity factors were identified in both periods: transplant and multiorgan disease; cardiometabolic disorder; substance use, psychiatric disorder, and liver disease; and obesity. After COVID-19, the leading pattern among PWH shifted toward cardiometabolic disorder. Conclusions PWH experience a disproportionately high multimorbidity burden, with disparities further amplified after COVID-19 diagnosis and the leading pattern shifting toward cardiometabolic dominance. These findings highlight the need for integrated, multimorbidity-focused care for PWH.
Reference Key
openalex_W7213609112 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag560
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.